How Amyotrophic Lateral Sclerosis Contributes to Increased Venous Thromboembolism Risk

Authors

  • Abdullah Ashraf Hamad Faculty of Medicine, Menoufia University, Menoufia, Egypt. Medical Research Group of Egypt, Negida Academy, Arlington, MA, USA

DOI:

https://doi.org/10.62438/tunismed.v103i3.5734

Keywords:

amyotrophic lateral sclerosis, anticoagulant, neurodegenerative diseases, pulmonary embolism, venous thromboembolism

Abstract

.

Downloads

Download data is not yet available.

References

Immobile ALS patients or those at risk of venous thromboembolism require a comprehensive examination and low-dose heparinisation. Tunis Med.

Hamad AA, Alkhawaldeh IM, Abbas A, et al. Incidence and risk factors of venous thromboembolism in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Tunis Med 2024; 102: 610–615.

Goldacre R, Trubshaw M, Morris EJA, et al. Venous thromboembolism risk in amyotrophic lateral sclerosis: a hospital record-linkage study. J Neurol Neurosurg Psychiatry 2024; jnnp-2024-333399.

Lu C-H, Allen K, Oei F, et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflammation; 3. Epub ahead of print August 2016. DOI: 10.1212/NXI.0000000000000244.

Branchford BR, Carpenter SL. The Role of Inflammation in Venous Thromboembolism. Front Pediatr; 6. Epub ahead of print 23 May 2018. DOI: 10.3389/fped.2018.00142.

Fukui Y, Hishikawa N, Shang J, et al. Peripheral arterial endothelial dysfunction of neurodegenerative diseases. J Neurol Sci 2016; 366: 94–99.

Additional Files

Published

2025-03-02

Issue

Vol. 103 No. 3 (2025): Tunis Med Mar 2025

Section

Author's response to letter to the editor

Categories

License

Copyright (c) 2025 La Tunisie Médicale

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.